In the search for potential biomarkers to predict the success of renal sympathetic denervation in patients with resistant hypertension (n = 55), Dörr et al. measured the serum levels of key factors associated with endothelial function: fms-like tyrosine kinase-1 (sFLT-1), intercellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). Baseline levels of sFLT-1, ICAM-1 and VCAM-1 were all significantly higher in those who achieved a reduction in systolic blood pressure of >10 mmHg 6 months after renal sympathetic denervation (n = 46) than in nonresponders, suggesting these factors might be useful clinical biomarkers.